NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $7,000 | -12.5% | 84 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $8,000 | +14.3% | 84 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $7,000 | 0.0% | 84 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $7,000 | 0.0% | 84 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $7,000 | -12.5% | 84 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $8,000 | -46.7% | 84 | -50.6% | 0.00% | -50.0% |
Q3 2019 | $15,000 | -84.8% | 170 | -84.3% | 0.00% | -85.7% |
Q2 2019 | $99,000 | +106.2% | 1,084 | +119.0% | 0.03% | +115.4% |
Q1 2019 | $48,000 | +14.3% | 495 | 0.0% | 0.01% | +8.3% |
Q4 2018 | $42,000 | -2.3% | 495 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $43,000 | -15.7% | 495 | -3.9% | 0.01% | -53.8% |
Q2 2015 | $51,000 | +142.9% | 515 | +139.5% | 0.03% | +136.4% |
Q1 2015 | $21,000 | +5.0% | 215 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $20,000 | 0.0% | 215 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $20,000 | +5.3% | 215 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $19,000 | +5.6% | 215 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $18,000 | +5.9% | 215 | 0.0% | 0.01% | 0.0% |
Q4 2013 | $17,000 | – | 215 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |